This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Distinct Clinical Entity?

Alexander H. Glassman, MD; Steven P. Roose, MD

Arch Gen Psychiatry. 1981;38(4):424-427.

Abstract
• The prognostic importance of delusions in the depressive syndrome had been a major focus of study before somatic therapies were available. Recently, the growing evidence that delusional depressives respond at a significantly lower rate to tricyclic antidepressants than do nondelusional depressives has revived this interest. That evidence is reviewed, and the demographic data and pretreatment clinical phenomenology of a series of hospitalized depressed patients were analyzed to see if differences existed between the delusional and nondelusional groups. Delusional unipolar depressives were less likely to recover while receiving placebo, had significantly more psychomotor retardation, and showed a trend toward fewer previous episodes than nondelusional unipolar depressives.

Author Affiliations
From the Department of Clinical Psychopharmacology, New York State Psychiatric Institute, New York (Dr Glassman); and the Department of Psychiatry, Columbia University, New York (Drs Glassman and Roose). Dr Roose is a Research Fellow in Schizophrenia and Affective Disorders at the New York State Psychiatric Institute.

Footnotes
Accepted for publication Aug 6, 1980.

Reprint requests to Office of Mental Health, New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Glassman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Double-blind Randomized Controlled Trial of Olanzapine Plus Sertraline vs Olanzapine Plus Placebo for Psychotic Depression: The Study of Pharmacotherapy of Psychotic Depression (STOP-PD)
Meyers et al.
Arch Gen Psychiatry 2009;66:838-847.
ABSTRACT | FULL TEXT  

What was the Mental Disease that Afflicted King Saul?
Ben-Noun
Clinical Case Studies 2003;2:270-282.
ABSTRACT  

National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders
Charney et al.
Arch Gen Psychiatry 2002;59:262-270.
ABSTRACT | FULL TEXT  

The Validity of Major Depression With Psychotic Features Based on a Community Study
Johnson et al.
Arch Gen Psychiatry 1991;48:1075-1081.
ABSTRACT  

Hospital Utilization and Readmission Rates for Geriatric and Young Adult Patients With Major Depression: Results From a Historical Cohort Study
Colenda et al.
J Geriatr Psychiatry Neurol 1991;4:166-172.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Imipramine in Prepubertal Major Depressive Disorders
Puig-Antich et al.
Arch Gen Psychiatry 1987;44:81-89.
ABSTRACT  

Electroencephalographic Sleep in Psychotic Depression: A Valid Subtype?
Thase et al.
Arch Gen Psychiatry 1986;43:886-893.
ABSTRACT  

Effect of 5-Hydroxytryptophan on Serum Cortisol Levels in Major Affective Disorders: II. Relation to Suicide, Psychosis, and Depressive Symptoms
Meltzer et al.
Arch Gen Psychiatry 1984;41:379-387.
ABSTRACT  

Primary Unipolar Depression and the Prognostic Importance of Delusions
Coryell and Tsuang
Arch Gen Psychiatry 1982;39:1181-1184.
ABSTRACT